{"id":4872,"date":"2025-03-25T13:29:11","date_gmt":"2025-03-25T13:29:11","guid":{"rendered":"https:\/\/www.nordicbioscience.com\/?post_type=biomarker-solution&p=4872"},"modified":"2025-06-13T09:52:48","modified_gmt":"2025-06-13T09:52:48","slug":"oncology","status":"publish","type":"biomarker-solution","link":"https:\/\/www.nordicbioscience.com\/biomarker-solution\/oncology\/","title":{"rendered":"Oncology"},"content":{"rendered":"
\n
\n
\n

Biomarkers for Oncology <\/h1>\n

In this section, you can find out how our unique markers can help your cancer study. We are leaders in measuring tumor fibrosis, a highly relevant component of the tumor microenvironment, and we also offer a selection of non-invasive immune activity biomarkers. <\/p>\n

\n \n Browse cancer biomarkers \n \n <\/svg>\n \n <\/a>\n <\/div>\n <\/article>\n <\/div>\n<\/section>\n\n\n\n\n
\n \n
\n
\n
\n
\n

Cancer biomarkers for immuno-oncology<\/h2>\n \n\n <\/div>\n
\n

This section provides a brief\u00a0overview of our most popular immuno-oncology biomarkers. We have developed a non-invasive method to look at activation of T-cells, macrophages and neutrophils. Understand pharmacodynamics, Mode of Action and efficacy non-invasively.<\/p>\n

Therefore, it is important to identify patients with a T-cell permissive tumor microenvironment.<\/p>\n <\/div>\n

\n

Publications<\/h3>\n